NCT06732622 Laser Acupuncture for Idiopathic Bell's Palsy
| NCT ID | NCT06732622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tongren Hospital |
| Condition | Bell Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2024-12-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bell's palsy is characterized by acute, unilateral onset that compromises function and esthetics, exerting a considerable impact on the social, professional, and psychological aspects of the lives of affected individuals. The objective of this study was to determine whether laser acupuncture therapy could relieve symptoms in patients with Bell's palsy.
Eligibility Criteria
Inclusion Criteria: * 1\. Patients diagnosed with idiopathic Bell's Palsy 2.Patients were eligible if they were graded at House-Brackmann grade (HB) 3 or higher. Exclusion Criteria: * 1\. Serious mental illness or social problems, and neurological disorders, and systemic diseases, such as malignant tumors, and other serious consumptive diseases. 2. Planning for pregnancy, those in pregnancy, or those who were lactating. 3.Bell's Palsy patients who have a disease course of more than 8 weeks.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06732622 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Bell Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06732622 currently recruiting?
Yes, NCT06732622 is actively recruiting participants. Contact the research team at wudong0120@outlook.com for enrollment information.
Where is the NCT06732622 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06732622 clinical trial?
NCT06732622 is sponsored by Beijing Tongren Hospital. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.